Blake Schutter Theil Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$205K Buy
+7,200
New +$192K 0.14% 109
2026
Q2
– Sell
-7,228
Closed -$203K – 116
2026
Q1
$203K Sell
7,228
-1,037
-13% -$27.6K 0.17% 110
2025
Q4
$206K Sell
8,265
-710
-8% -$17.9K 0.17% 106
2025
Q3
$229K Sell
8,975
-3,440
-28% -$84.9K 0.23% 100
2025
Q2
$301K Sell
12,415
-1,239
-9% -$28.9K 0.34% 84
2025
Q1
$346K Sell
13,654
-235
-2% -$6.15K 0.39% 80
2024
Q4
$368K Buy
13,889
+3,461
+33% +$93.9K 0.39% 74
2024
Q3
$302K Buy
+10,428
New +$304K 0.22% 114

Other funds holding PFE

Blake Schutter Theil Wealth Advisors's PFE Position: Q3 2026 in Review

Blake Schutter Theil Wealth Advisors opened a new position in Pfizer (PFE) in Q3 2026: 7,200 shares worth $205K. The stake represents 0.14% of the portfolio and ranks #109 among its holdings. This is a return to the name: Blake Schutter Theil Wealth Advisors previously reported a position in PFE as recently as Q1 2026.

Blake Schutter Theil Wealth Advisors first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $368K in Q4 2024. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Blake Schutter Theil Wealth Advisors held 7,200 shares of Pfizer worth $205K as of Q3 2026.
  • Pfizer was a new Blake Schutter Theil Wealth Advisors position in Q3 2026.
  • Pfizer made up 0.14% of Blake Schutter Theil Wealth Advisors's portfolio in Q3 2026, its #109 holding.
  • Blake Schutter Theil Wealth Advisors first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • Blake Schutter Theil Wealth Advisors's Pfizer position peaked at $368K in Q4 2024.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Blake Schutter Theil Wealth Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.